NBTX – nanobiotix s.a. - adss (US:NASDAQ)

News

NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
Voting Rights and Shares Capital of the Company
NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
Voting Rights and Shares Capital of the Company
NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com